Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-04-07 00:00:00 ET · period of report 2022-04-05 · accession 0001883850-22-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-04-07 | 2022-04-05+ | REGN | SCHLEIFER LEONARD S | Pres, CEO, Dir | S - Sale | $710.05 | -7,114 | 13.8K | -34% | -$5.05M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-06 | S | D | 2,653 | $710.04 | 11,178 | I By Trust | — | — | (F3) Represents volume-weighted average price of sales of 2,653 shares of Company stock on April 6, 2022 at prices ranging from $710.00 to $710.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 6, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-04-05 | S | D | 4,461 | $710.05 | 13,831 | I By Trust | — | — | (F2) Represents volume-weighted average price of sales of 4,461 shares of Company stock on April 5, 2022 at prices ranging from $710.00 to $710.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 5, 2022 at each separate price. |